[Microvessel density and expression of vascular endothelial growth factor in adenoid cystic carcinoma of salivary gland]. 2003

Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
Department of Stomatology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China. yf91.yu@vip.sina.com

OBJECTIVE To discern whether the microvessel density (MVD) and the expression of vascular endothelial growth factor (VEGF) could be prognostic indicators for the metastasis and survival of patients with SACC after radical surgery. METHODS After the follow-up of 31 primary patients with SACC treated with radical surgeries for at least 60 months, the paraffin-bedded sections of the those patients were stained immunohistochemically with anti-CD34-McAb and anti-VEGF-McAb, respectively. Subsequently, two pathologists double-blindly evaluated the sections stained with anti-CD34-McAb to determine the MVD values individually, as well as, measured the sections stained with the ani-VEGF-McAb to determine the OD values. Consequently the data were analyzed with the statistic software package detailed. RESULTS The univariate statistical analysis showed that the pathological types of SACC, the TNM stages, MVD and OD values were all statistically significant variables for the survival of the patients with SACC (P = 0.047, 0.000, 0.000, 0.024). Furthermore, among those reliable variables, only MVD was more significant in the Cox proportional hazard model for the multivariate analyses (P = 0.000). The MVD values were statistically significantly higher, in the group with either death, or metastasis, or tumor-relapse, or worse pathological types, or advanced TNM stages, than their counterparts respectively(P = 0.029, 0.045, 0.019, 0.031, 0.00). On the other hand, the OD values were also statistically significantly higher, in the group with either death, or worse pathological types, or advanced TNM stages, than their counterparts respectively(P = 0.037, 0.013, 0.014). The results of Fisher exact test showed that the incidence of distant metastasis differed statistically significantly between the subgroups divided with the median of the MVD values (P = 0.032). The stepwise linear regression equation showed that the MVD value correlated positively with the OD value (P = 0.029). CONCLUSIONS The MVD value and the expression level of VEGF all have statistically significant correlations with the survival of the patients with SACC, moreover, the MVD value is more significant as a prognostic indicator. The MVD value could also be a prognostic indicator for the incidence of the distant metastasis of patients with SACC. The over-expression of VEGF in SACC might contribute to the MVD values increasing.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003528 Carcinoma, Adenoid Cystic Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed) Cylindroma,Adenocystic Carcinoma,Adenocystic Carcinomas,Adenoid Cystic Carcinoma,Adenoid Cystic Carcinomas,Carcinoma, Adenocystic,Carcinomas, Adenocystic,Carcinomas, Adenoid Cystic,Cylindromas,Cystic Carcinoma, Adenoid,Cystic Carcinomas, Adenoid
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012468 Salivary Gland Neoplasms Tumors or cancer of the SALIVARY GLANDS. Cancer of Salivary Gland,Non-Sebaceous Lymphadenomas,Salivary Gland Cancer,Salivary Gland Lymphadenomas,Sebaceous Lymphadenomas,Cancer of the Salivary Gland,Neoplasms, Salivary Gland,Cancer, Salivary Gland,Cancers, Salivary Gland,Gland Neoplasm, Salivary,Gland Neoplasms, Salivary,Lymphadenoma, Non-Sebaceous,Lymphadenoma, Salivary Gland,Lymphadenoma, Sebaceous,Lymphadenomas, Non-Sebaceous,Lymphadenomas, Salivary Gland,Lymphadenomas, Sebaceous,Neoplasm, Salivary Gland,Non Sebaceous Lymphadenomas,Non-Sebaceous Lymphadenoma,Salivary Gland Cancers,Salivary Gland Lymphadenoma,Salivary Gland Neoplasm,Sebaceous Lymphadenoma
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
May 2001, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology,
Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
April 2016, Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology,
Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
December 2022, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery,
Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
February 2014, Anticancer research,
Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
July 2001, Journal of the Formosan Medical Association = Taiwan yi zhi,
Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
January 2003, The breast journal,
Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
April 2001, Proceedings of the National Science Council, Republic of China. Part B, Life sciences,
Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
March 2010, International journal of oral science,
Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
June 2008, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Feng Yu, and Xiao-zhong Jiang, and Wan-tao Chen, and Yun-fu Zhao, and Xiao-jian Zhou
May 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Copied contents to your clipboard!